This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cagnacci, S.
Right arrow Articles by Marchese, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cagnacci, S.
Right arrow Articles by Marchese, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2008, p. 2605-2612, Vol. 46, No. 8
0095-1137/08/$08.00+0     doi:10.1128/JCM.00640-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

European Emergence of Ciprofloxacin-Resistant Escherichia coli Clonal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis{triangledown}

Simone Cagnacci, Laura Gualco, Eugenio Debbia, Gian Carlo Schito, and Anna Marchese*

Sezione di Microbiologia del Di.S.C.A.T., University of Genoa, Genoa, Italy

Received 4 April 2008/ Returned for modification 16 May 2008/ Accepted 12 June 2008

A total of 148 E. coli strains displaying reduced susceptibility to ciprofloxacin (MIC ≥ 2 µg/ml) and causing uncomplicated urinary tract infections in eight European countries during 2003 to 2006 were studied. Their phylogenetic groups, biochemical profiles, and antibiotic susceptibilities were determined. Determination of the O:H serotype, pulsed-field gel electrophoresis (PFGE), randomly amplified polymorphic DNA (RAPD) PCR, and multilocus sequence typing provided additional discrimination. The majority (82.4%) of the microorganisms (122/148) carried resistance to two or more additional drugs, with the pattern ciprofloxacin-trimethoprim-sufamethoxazole-tetracycline-ampicillin being the most represented (73 strains out of 148; 49.3%). Extended-spectrum beta-lactamase production was detected in 12/148 strains (8.1%), with CTX-M-15 being the most-common enzyme. Six strains out of the whole collection studied (4.0%) contained a qnrB-like gene. Overall, 55 different PFGE or RAPD PCR profiles could be distinguished, indicating a substantial heterogeneity. However, about one-third (51/148) of the strains belonged to two clonal groups: O15:K52:H1 (phylogenetic group B2, lactose-nonfermenting variant, ciprofloxacin MIC of 16 µg/ml) and O25:H4 sequence type 131 (ST-131) (phylogenetic group D, ciprofloxacin MIC of ≥32 µg/ml). With the exception of Poland, strains of these two groups were isolated in samples from all participating countries but more frequently in samples from Spain and Italy. In some representative strains of the two main clonal groups, alterations in GyrA and ParC were the basic mechanism of fluoroquinolone resistance. In some members of the O25:H4 ST-131 group, displaying a ciprofloxacin MIC of >32 µg/ml, additional OmpF loss or pump efflux overexpression was found. In the Mediterranean area, strains belonging to these two clonal groups played a major role in determining the high rate of fluoroquinolone-resistant E. coli strains observed in the community.


* Corresponding author. Mailing address: Sezione di Microbiologia del Di.S.C.A.T., University of Genoa, Largo R. Benzi, 10, 16132 Genoa, Italy. Phone: 39-010-3537502. Fax: 39-010-3537655. E-mail: anna.marchese{at}unige.it

{triangledown} Published ahead of print on 25 June 2008.


Journal of Clinical Microbiology, August 2008, p. 2605-2612, Vol. 46, No. 8
0095-1137/08/$08.00+0     doi:10.1128/JCM.00640-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Valverde, A., Canton, R., Garcillan-Barcia, M. P., Novais, A., Galan, J. C., Alvarado, A., de la Cruz, F., Baquero, F., Coque, T. M. (2009). Spread of blaCTX-M-14 Is Driven Mainly by IncK Plasmids Disseminated among Escherichia coli Phylogroups A, B1, and D in Spain. Antimicrob. Agents Chemother. 53: 5204-5212 [Abstract] [Full Text]  
  • Martinez-Medina, M., Mora, A., Blanco, M., Lopez, C., Alonso, M. P., Bonacorsi, S., Nicolas-Chanoine, M.-H., Darfeuille-Michaud, A., Garcia-Gil, J., Blanco, J. (2009). Similarity and Divergence among Adherent-Invasive Escherichia coli and Extraintestinal Pathogenic E. coli Strains. J. Clin. Microbiol. 47: 3968-3979 [Abstract] [Full Text]  
  • Johnson, J. R., Miller, S., Johnston, B., Clabots, C., DebRoy, C. (2009). Sharing of Escherichia coli Sequence Type ST131 and Other Multidrug-Resistant and Urovirulent E. coli Strains among Dogs and Cats within a Household. J. Clin. Microbiol. 47: 3721-3725 [Abstract] [Full Text]  
  • Duval, V., Maiga, I., Maiga, A., Guillard, T., Brasme, L., Forte, D., Madoux, J., Vernet-Garnier, V., De Champs, C. (2009). High Prevalence of CTX-M-Type {beta}-Lactamases among Clinical Isolates of Enterobacteriaceae in Bamako, Mali. Antimicrob. Agents Chemother. 53: 4957-4958 [Full Text]  
  • Maraki, S., Samonis, G., Rafailidis, P. I., Vouloumanou, E. K., Mavromanolakis, E., Falagas, M. E. (2009). Susceptibility of Urinary Tract Bacteria to Fosfomycin. Antimicrob. Agents Chemother. 53: 4508-4510 [Abstract] [Full Text]  
  • Pitout, J. D. D., Gregson, D. B., Campbell, L., Laupland, K. B. (2009). Molecular Characteristics of Extended-Spectrum-{beta}-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections. Antimicrob. Agents Chemother. 53: 2846-2851 [Abstract] [Full Text]  
  • Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K., Zhanel, G. G. (2009). Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53: 2733-2739 [Abstract] [Full Text]  
  • Arpin, C., Quentin, C., Grobost, F., Cambau, E., Robert, J., Dubois, V., Coulange, L., Andre, C., on behalf of the Scientific Committee of ONERBA, (2009). Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother 63: 1205-1214 [Abstract] [Full Text]  
  • Olesen, B., Scheutz, F., Menard, M., Skov, M. N., Kolmos, H. J., Kuskowski, M. A., Johnson, J. R. (2009). Three-Decade Epidemiological Analysis of Escherichia coli O15:K52:H1. J. Clin. Microbiol. 47: 1857-1862 [Abstract] [Full Text]  
  • Pitout, J. D. D., Campbell, L., Church, D. L., Gregson, D. B., Laupland, K. B. (2009). Molecular Characteristics of Travel-Related Extended-Spectrum-{beta}-Lactamase-Producing Escherichia coli Isolates from the Calgary Health Region. Antimicrob. Agents Chemother. 53: 2539-2543 [Abstract] [Full Text]  
  • Pitout, J. D. D., Campbell, L., Church, D. L., Wang, P. W., Guttman, D. S., Gregson, D. B. (2009). Using a Commercial DiversiLab Semiautomated Repetitive Sequence-Based PCR Typing Technique for Identification of Escherichia coli Clone ST131 Producing CTX-M-15. J. Clin. Microbiol. 47: 1212-1215 [Abstract] [Full Text]  
  • Jones, G. Ll., Warren, R. E., Skidmore, S. J., Davies, V. A., Gibreel, T., Upton, M. (2008). Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum {beta}-lactamases. J Antimicrob Chemother 62: 1245-1251 [Abstract] [Full Text]